N4-Cyclohexyl-N2-(2-methoxy-4-morpholinophenyl)-7Hpyrrolo[2,3-d]pyrimidine-2,4-diamine

ID: ALA4076767

PubChem CID: 121320416

Max Phase: Preclinical

Molecular Formula: C23H30N6O2

Molecular Weight: 422.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N2CCOCC2)ccc1Nc1nc(NC2CCCCC2)c2cc[nH]c2n1

Standard InChI:  InChI=1S/C23H30N6O2/c1-30-20-15-17(29-11-13-31-14-12-29)7-8-19(20)26-23-27-21-18(9-10-24-21)22(28-23)25-16-5-3-2-4-6-16/h7-10,15-16H,2-6,11-14H2,1H3,(H3,24,25,26,27,28)

Standard InChI Key:  YIGQSLKUNKHIBI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
    9.8291  -11.4534    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1218  -11.8623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4107  -11.4483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4146  -10.6275    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1239  -10.2221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8346  -10.6382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5418  -11.8659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2512  -11.4605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9582  -11.8745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9564  -12.6918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2491  -13.1007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5343  -12.6846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6640  -13.0964    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3755  -12.6868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0911  -13.0964    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7943  -12.6868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7943  -11.8674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0911  -11.4619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3755  -11.8674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5686  -12.9353    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5686  -11.6174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0475  -12.2729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0911  -10.6369    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3762  -10.2252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3762   -9.4059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6730   -8.9962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9615   -9.4059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9615  -10.2252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6730  -10.6349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2478  -13.9179    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5395  -14.3254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  7 12  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 14 19  2  0
 21 22  2  0
 20 22  1  0
 16 20  1  0
 17 21  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 24 29  1  0
 23 24  1  0
 18 23  1  0
 13 14  1  0
 10 13  1  0
  1  7  1  0
 11 30  1  0
 30 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4076767

    ---

Associated Targets(Human)

CAL-51 (262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC1937 (423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-20 (503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-549 (31254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-436 (532 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-468 (9477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hs-578T (29457 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAMA-1 (145 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-BR-3 (5175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AU565 (191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-453 (1139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-474 (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TTK Tchem Dual specificity protein kinase TTK (2978 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTK2 Tclin Focal adhesion kinase 1 (4730 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK8 Tchem c-Jun N-terminal kinase 1 (5038 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SYK Tclin Tyrosine-protein kinase SYK (7372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYK2 Tclin Tyrosine-protein kinase TYK2 (5029 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CB Tchem PI3-kinase p110-beta subunit (4044 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 422.53Molecular Weight (Monoisotopic): 422.2430AlogP: 4.29#Rotatable Bonds: 6
Polar Surface Area: 87.33Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.40CX Basic pKa: 6.61CX LogP: 4.23CX LogD: 4.17
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.55Np Likeness Score: -1.41

References

1. Sugimoto Y, Sawant DB, Fisk HA, Mao L, Li C, Chettiar S, Li PK, Darby MV, Brueggemeier RW..  (2017)  Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancer.,  25  (7): [PMID:28259529] [10.1016/j.bmc.2017.02.030]

Source